NZ560737A - Analgesic and anti-inflammatory composition - Google Patents

Analgesic and anti-inflammatory composition

Info

Publication number
NZ560737A
NZ560737A NZ560737A NZ56073706A NZ560737A NZ 560737 A NZ560737 A NZ 560737A NZ 560737 A NZ560737 A NZ 560737A NZ 56073706 A NZ56073706 A NZ 56073706A NZ 560737 A NZ560737 A NZ 560737A
Authority
NZ
New Zealand
Prior art keywords
mixture
metal
composition
plasma
serum
Prior art date
Application number
NZ560737A
Other languages
English (en)
Inventor
Jeffrey D Edward
John Palermo
Maud Louisa Johanna Maria Eijkenboom
Original Assignee
Cambridge Scient Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005900638A external-priority patent/AU2005900638A0/en
Priority claimed from US11/059,580 external-priority patent/US7510732B2/en
Application filed by Cambridge Scient Pty Ltd filed Critical Cambridge Scient Pty Ltd
Publication of NZ560737A publication Critical patent/NZ560737A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ560737A 2005-02-11 2006-02-10 Analgesic and anti-inflammatory composition NZ560737A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2005900638A AU2005900638A0 (en) 2005-02-11 Analgesic and anti-inflammatory composition
US11/059,580 US7510732B2 (en) 2005-02-16 2005-02-16 Analgesic and anti-inflammatory composition
PCT/AU2006/000185 WO2006084334A1 (fr) 2005-02-11 2006-02-10 Préparation analgésique et anti-inflammatoire

Publications (1)

Publication Number Publication Date
NZ560737A true NZ560737A (en) 2010-01-29

Family

ID=36792852

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ560737A NZ560737A (en) 2005-02-11 2006-02-10 Analgesic and anti-inflammatory composition

Country Status (4)

Country Link
EP (1) EP1853281A4 (fr)
CA (1) CA2597431A1 (fr)
NZ (1) NZ560737A (fr)
WO (1) WO2006084334A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070048387A1 (en) * 2005-09-01 2007-03-01 Edwards Jeffrey D Tissue disruption treatment and composition for use thereof
EP2032147A4 (fr) * 2006-04-28 2011-02-02 Cambridge Scient Pty Ltd Inhibiteur de l'enzyme cox-2
WO2007124540A1 (fr) * 2006-04-28 2007-11-08 Cambridge Scientific Pty Ltd Composition de médiation de la cytokine
AU2008294074B2 (en) 2007-08-30 2015-01-22 Walter And Eliza Hall Institute Of Medical Research Dendritic cell marker and uses thereof
JP2022505915A (ja) * 2018-10-26 2022-01-14 アルカヘスト，インコーポレイテッド 疼痛、創傷治癒及び術後回復の改善のための血漿及び血漿画分の使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2579367A (en) * 1950-11-24 1951-12-18 Hynson Westcott & Dunning Inc Bandage
GB931016A (en) * 1960-12-22 1963-07-10 Distillers Co Yeast Ltd Amino acids concentrate and intravenous preparations thereof
JPS5220524B1 (fr) * 1968-11-02 1977-06-04
EP0061556B1 (fr) * 1979-11-16 1984-10-03 AB Pripps Bryggerier Préparation d'acides aminés enrichie en fer hématinique et procédé pour la confection de préparations d'acides aminés enrichies en fer hématinique à partir d'hémoprotéines
FR2651679B1 (fr) * 1989-09-08 1994-06-03 Imedex Application d'hydrolysats de globines pour la stimulation cellulaire et produits pharmaceutiques et cosmetiques obtenus.
JP3578627B2 (ja) * 1998-05-15 2004-10-20 株式会社ホギメディカル 創傷患部の治癒を促進する組織シーラント
RU2221456C1 (ru) * 2003-03-11 2004-01-20 Общество с ограниченной ответственностью "Арсентех" Биологически активное вещество, биологически активная добавка к пище, фармацевтический препарат, биологически активная добавка для кормления животных, ветеринарный препарат, удобрение, активатор микробиологических процессов, пероральное питание, парфюмерно-косметическое средство, гигиеническое средство, молочный продукт, кондитерское изделие, хлебобулочное изделие, масло-жировой продукт, соус, алкогольный напиток, безалкогольный напиток, рыбный продукт, мясной продукт, макаронные изделия, жевательная резинка, пиво

Also Published As

Publication number Publication date
WO2006084334A1 (fr) 2006-08-17
EP1853281A1 (fr) 2007-11-14
EP1853281A4 (fr) 2010-07-14
CA2597431A1 (fr) 2006-08-17

Similar Documents

Publication Publication Date Title
AU2007246167B2 (en) COX-2 inhibitor
US8617893B2 (en) Analgesic and anti-inflammatory composition
US20110098284A1 (en) Methods and compositions for treating pain
WO2008115572A1 (fr) Procédés et compositions d'ains
US20150064164A1 (en) Tissue disruption treatment and composition for use thereof
US10463690B2 (en) Method and compositions for treating cancerous tumors
NZ560737A (en) Analgesic and anti-inflammatory composition
WO2008150324A1 (fr) Doses subanalgésiques d'associations médicamenteuses
EP3417708B1 (fr) Administration d'ibuprofène par voie intraveineuse
AU2006212722B2 (en) Analgesic and anti-inflammatory composition
AU2007246166B2 (en) Cytokine mediating composition
Smith et al. Drug Therapy in Laryngology and Head and Neck Surgery

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed
S883 Correction of error according to section 88(3) (mistake in register caused on part of patentee or applicant)

Free format text: CORRECTION TO INVENTORS (72)

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 10 FEB 2016 BY CPA GLOBAL

Effective date: 20130103

LAPS Patent lapsed